Type I interferon induces inhibitory 16-kD CCAAT/enhancer binding protein (C/EBP)β, repressing the HIV-1 long terminal repeat in macrophages: Pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication

Journal of Experimental Medicine

Volumn 188, Issue 7, 1998, Pages 1255-1265

  Honda, Yoshihiro ^a,c   Rogers, Linda ^a   Nakata, Koh ^b   Zhao, Ben Yang ^d   Pine, Richard ^d   Nakai, Yushi ^c   Kurosu, Katsushi ^a   Rom, William N ^a   Weiden, Michael ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b THE UNIVERSITY OF TOKYO   (Japan)

^c Sendai Kosei Hospital   (Japan)

^d PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

CCAAT enhancer binding protein ; HIV 1 long terminal repeat; Interferon ; Repression; Tuberculosis

Indexed keywords

DNA BINDING PROTEIN; INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; LEUKOCYTE DIFFERENTIAL COUNT; LONG TERMINAL REPEAT; LUNG ALVEOLUS MACROPHAGE; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS REPLICATION;

BASE SEQUENCE; BINDING SITES; BRONCHOALVEOLAR LAVAGE; CCAAT-ENHANCER-BINDING PROTEINS; DNA, VIRAL; DNA-BINDING PROTEINS; DOWN-REGULATION; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; MACROPHAGES; MACROPHAGES, ALVEOLAR; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TUBERCULOSIS, PULMONARY; VIRUS REPLICATION;

EID: 0032487523     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.7.1255     Document Type: Article

References (48)

1. Nakata, K., M. Weiden, T. Harkin, D. Ho, and W.N. Rom. 1995. Low copy number and limited variability of proviral DNA in alveolar macrophages from HIV-1 infected patients: evidence for genetic differences in HIV-1 between lung and blood macrophage populations. Mol. Med. 1:744-757.
2. Nakata, K., W.N. Rom, Y. Honda, R. Condos, S. Kanegasaki, Y. Cao, and M. Weiden. 1997. M. tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am. J. Respir. Crit. Care Med. 155:996-1003.
3. Itescu, S., P.F. Simonelli, R.J. Winchester, and H.S. Ginsberg. 1994. Human immunodeficiency virus type 1 strains in the lungs of infected individuals evolve independently from those in the peripheral blood and are highly conserved in the C-terminal region of the envelope V3 loop. Proc. Natl. Acad. Sci. USA. 91:11378-11382.
4. Israel-Biet, D., J. Cadranel, K. Beldjord, J. Andrieu, A. Jeffrey, and P. Even. 1991. Tumor necrosis factor production in HIV-seropositive subjects: relationship with lung opportunistic infections and HIV expression in alveolar macrophages. J. Immunol. 147:490-494.
5. Sierra-Madero, J., Z. Toossi, D. Hom, C. Finegan, E. Hoenig, and E. Rich. 1994. Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status. J. Infect. Dis. 169:18-27.
6. Orenstein, J.M., C. Fox, and S.M. Whal. 1997. Macrophages as a source of HIV during opportunistic infections. Science. 276:1857-1861.
7. Whalen, C., C.R. Horsburgh, D. Hom, C. Lahart, M. Simberkoff, and J. Ellner. 1995. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am. J. Respir. Crit. Care Med. 151:129-135.
8. Bernstein, M.S., S.E. Tong-Starksen, and R.M. Locksley. 1991. Activation of human monocyte-derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication at the level of gene expression. J. Clin. Invest. 88:540-545.
9. Kornbluth, R.S., P.S. Oh, J.R. Munis, P.H. Cleveland, and D.D. Richman. 1989. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169: 1137-1151.
10. Herbein, G., and S. Gordon. 1997. 55- and 75-kilodalton tumor necrosis factor receptors mediate distinct actions in regard to human immunodeficiency virus type 1 replication in primary human macrophages. J. Virol. 71:4150-4156.
11. Gessani, S., U. Testa, B. Varano, P. Di Marzio, P. Borghi, L. Conti, T. Barberi, E. Tritarelli, R. Martucci, D. Seripa, et al. 1993. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages: role of LPS receptors. J. Immunol. 151:3758-3766.
12. Hamilton, J.A., W.A. Genevieve, I. Kola, and P.J. Hertzog. 1996. Endogenous Interferon-α/β suppresses colony-stimulating factor (CSF-1) stimulated macrophage DNA synthesis and mediates inhibitory effects of LPS and TNF-α. J. Immunol. 156:2553-2557.
13. Hwang, S., P.J. Herzog, K. Holland, S. Sumarsono, M.J. Tymms, J.A. Hamilton, G. Whitry, I. Bertoncello, and I. Kola. 1995. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferon α and β and alters macrophage responses. Proc. Natl. Acad. Sci. USA. 92:11284-11288.
14. van der Broek, M., U. Muller, S. Huang, R. Zinkernagel, and M. Aguet. 1995. Immune defense in mice lacking type I and/or type II interferon receptors. Immunol. Rev. 148:5-18.
15. Khan, N., A. Pulford, M. Farquharson, A. Howatson, C. Stewart, R. Jackson, A. McNicol, and A. Foulis. 1989. The distribution of immunoreactive interferon-alpha in normal human tissues. Immunology. 66:201-206.
16. Novic, D., B. Cohen, and M. Rubenstein. 1994. The human interferon β/β receptor: characterization and molecular cloning. Cell. 77:391-400.
17. Muller, U., U. Steinhoff, L. Reis, S. Hemmi, J. Povlovic, R. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264:1918-1921.
18. Bluyssen, H., J. Durbin, and D. Levy. 1996. ISGF3γ p48, a specificity switch for interferon-activated transcription factors. Cytokine Growth Factor Rev. 7:11-17.
19. Tesmer, V.M., A. Rajadhyaksha, J. Babin, and M. Bina. 1993. NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 90:7298-7303.
20. Descombes, P., and U. Schibler. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell. 67:569-579.
21. Ossipow, V., P. Descombes, and U. Schibler. 1993. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc. Natl. Acad. Sci. USA. 90:8219-8223.
22. Henderson, A.J., X. Zou, and K. Calame. 1995. C/EBP proteins activate transcription from human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J. Virol. 69:5337-5344.
23. Henderson, A.J., R.I. Connor, and K.L. Calame. 1996. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity. 5:91-101.
24. Henderson, A.J., and K.L. Calame. 1997. CCAAT/enhancer binding protein (C/EBP) sites are required tor HIV-1 replication in primary macrophages but not CD4+ T cells. Proc. Natl. Acad. Sci. USA. 94:8714-8719.
25. Sears, R., and L. Sealy. 1994. Multiple forms of C/EBPβ bind the EFII enhancer sequence in Rons sarcoma virus long terminal repeat. Mol. Cell. Biol. 14:4855-4871.
26. Pope, R.M., A. Lentz, and S.A. Ness. 1995. C/EBPβ regulation of the tumor necrosis factor α gene. J. Clin. Invest. 94: 1449-1455.
27. Dyer, R.B., and N.K. Herzog. 1995. Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cell line. Biotechniques. 19:192-195.
28. Pine, R. 1997. Convergence of TNFα and IFNγ signaling pathways through synergistic induction of IRF-1/ISGF-1 is mediated by a composite GAS/κB promoter element. Nucleic Acids Res. 25:4346-4354.
29. Law, K.F., J. Jagirdar, M. Weiden, M. Bodkin, and W.N. Rom. 1996. Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. Am. J. Respir. Crit. Care Med. 153:1377-1384.
30. Zhang, Y., K. Nakata, M. Weiden, and W.N. Rom. 1995. Mycobacterium tuberculosis enhances HIV-1 replication by transcriptional activation at the long terminal repeat. J. Clin. Invest. 95:2324-2331.
31. Orendi, J.M., H.S.L.M. Nottet, MR. Visser, A.F.M. Verheul, H. Snippe, and J. Verhoef. 1994. Enhancement of HIV-1 replication in peripheral blood mononuclear cells by Cryptococcus neoformans is monocyte-dependent but tumor necrosis factor-independent. AIDS (Lond.). 8:423-429.
32. Peterson, P.K., G. Gekker, C.C. Chao, S. Hu, C. Edelman, H.H. Balfour, and J. Verhoef. 1992. Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-a-mediated mechanism. J. Clin. Invest. 89:574-580.
33. Donovan, R.M., C.E. Bush, N.P. Markowitz, D.M. Baxa, and L.D. Saravolatz. 1996. Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. J. Infect. Dis. 174: 401-403.
34. Goletti, D., D. Weissman, R.W. Jackson, N.M.H. Graham, D. Vlahov, R.S. Klein, S.S. Munsiff, L. Ortona, R. Cauda, and A.S. Fauci. 1996. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J. Immunol. 157:1271-1278.
35. Poli, G., A.L. Kinter, E. Vicenzi, and A.S. Fauci. 1994. Interleukin-1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin-6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin-1 receptor antagonist. Proc. Natl. Acad. Sci. USA. 91: 108-112.
36. Pomerantz, R.J., M.B. Feinberg, D. Trono, and D. Baltimore. 1990. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficient virus type 1 expression. J. Exp. Med. 172:253-261.
37. Tadmori, W., D. Mondal, I. Tadmori, and O. Prakash. 1991. Transactivation of human immunodeficiency virus type 1 long terminal repeats by cell surface tumor necrosis factor α. J. Virol. 65:6425-6429.
38. Lu, Y., M. Stenzel, J. Sodroski, and W. Haseltine. 1989. Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication. J. Virol. 63:4115-4119.
39. Lu, Y., N. Touzjian, M. Stenzel, T. Dorfman, J. Sodroski, and W. Haseltine. 1990. Identification of cis-acting repressive sequences within the negative regulatory element of HIV-1. J. Virol. 64:5226-5229.
40. Rich, E., I. Chen, J. Zack, M. Leonard, and W. O'Brien. 1992. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1. J. Clin. Invest. 89:176-183.
41. Schuitemaker, H., N.A. Kootstra, M.H.G.M. Koppelman, S.M. Bruistein, H.G. Huisman, M. Tersmette, and F. Miedema. 1992. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J. Clin. Invest. 89:1154-1160.
42. Goletti, D., A. Kinter, P. Biswas, S. Bende, G. Poli, and A. Fauci. 1995. Effects of cellular differentiation on cytokine-induced expression of human immunodeficiency virus in chronically infected promonocytic cells: dissociation of cellular differentiation and viral expression. J. Virol. 69:2540-2546.
43. Natsuka, S., and S. Akira. 1992. Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin 6. Blood. 79:460-466.
44. Zhang, Y., M. Broser, and W.N. Rom. 1994. Activation of the interleukin-6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by NF-IL6 and NF-κB. Proc. Natl. Acad. Sci. USA. 91:2225-2229.
45. Zhang, Y., and W.N. Rom. 1993. Regulation of the interleukin-1β gene by mycobacterial components and lipopolysaccharide is mediated by two NF-IL6-like motifs. Mol. Cell. Biol. 13:3831-3837.
46. Vietor, I., I.C. Oliveira, and J. Vilcek. 1996. CCAAT box enhancer binding protein α (C/EBP-α) stimulates κB element-mediated transcription in transfected cells. J. Biol. Chem. 271:5595-5602.
47. Ruocco, M.R., X. Chen, C. Ambrosino, E. Dragonetti, W. Liu, M. Mallardo, G. De Falco, C. Palmieri, G. Franzoso, I. Quinto, et al. 1996. Regulation of HIV-1 long terminal repeats by interaction of C/EBP (NF-IL6) and NF-κB/rel transcription factors. J. Biol. Chem. 247:22479-22486.
48. An, M.R., C.C. Hsieh, P.D. Reisner, J.P. Rabek, S.G. Scott, D.T. Kuninger, and J. Papaconstantinou. 1996. Evidence for posttranscriptional regulation of C/EBPα and C/EBPβ isoform expression during lipopolysaccharide-mediated acute-phase response. Mol. Cell. Biol. 16:2295-2306.